This evening we watched CME drop -2.5% to a price of $211.76 per share. The large-cap Capital Markets company is now trading -7.3% below its average target price of $228.43. Analysts have set target prices ranging from $180.0 to $250.0 per share for CME, and have given the stock an average rating of buy.
The stock has a very low short interest at 1.0%, and a short ratio of 2.29. The company's insiders own 0.46% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 88.5% of CME's shares being owned by this investor type.
Institutions Invested in CME
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-06-30 | Vanguard Group Inc | 9% | 33,309,592 | $7,053,639,018 |
| 2023-09-30 | Blackrock Inc. | 6% | 23,241,387 | $4,921,595,983 |
| 2023-06-30 | JP Morgan Chase & Company | 4% | 15,984,554 | $3,384,889,067 |
| 2023-06-30 | State Street Corporation | 4% | 15,950,459 | $3,377,669,110 |
| 2023-06-30 | Capital International Investors | 4% | 13,996,964 | $2,963,997,019 |
| 2023-06-30 | Capital World Investors | 4% | 13,192,611 | $2,793,667,232 |
| 2023-09-30 | Capital Research Global Investors | 2% | 9,004,219 | $1,906,733,365 |
| 2023-09-30 | Geode Capital Management, LLC | 2% | 7,391,000 | $1,565,118,119 |
| 2023-09-30 | Bank Of New York Mellon Corporation | 2% | 7,091,141 | $1,501,619,979 |
| 2023-09-30 | Parnassus Investments, LLC | 2% | 5,643,801 | $1,195,131,268 |
Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on CME.
